Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.57
-0.08 (-1.20%)
Apr 10, 2026, 12:09 PM EDT - Market open
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $165.81 million as of April 10, 2026. Its market cap has increased by 151.33% in one year.
Market Cap
165.81M
Enterprise Value
126.68M
1-Year Change
151.33%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $165.81M, an increase of 149.38%. That is a compound annual growth rate of 21.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 167.83M | 35.34% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 176.45M |
| Corbus Pharmaceuticals Holdings | 172.22M |
| Achieve Life Sciences | 170.37M |
| Cartesian Therapeutics | 166.48M |
| Sagimet Biosciences | 165.53M |
| Artiva Biotherapeutics | 164.86M |
| Karyopharm Therapeutics | 162.54M |
| Whitehawk Therapeutics | 161.88M |